Default image

ClinicalTrials.gov

Connecting researchers with clinical trial opportunities

Providing a centralized resource for studies worldwide, ClinicalTrials.gov helps patients, families and professionals find information on ongoing and completed clinical trials. The platform promotes transparency in research by offering details on eligibility, locations and study objectives to support informed participation and collaboration.

Default image

Compliance & Policies

Providing essential guidance for safe and compliant operations, this collection of resources helps faculty, staff and trainees adhere to institutional health, safety and security standards. From laboratory protocols to emergency procedures, these materials are designed to support a culture of responsibility and ensure that all activities meet regulatory and institutional requirements.

Default image

Congenital Heart Disease Center

Children’s Discovery Institute

Focusing on the environmental and genetic origins of congenital heart and vascular disorders, our center is committed to advancing understanding of birth defects and related heart conditions. By integrating cutting-edge research with collaborative partnerships, we aim to uncover mechanisms that drive these diseases and translate discoveries into improved diagnostics and therapies for patients of all ages.

Default image

Cooper Lab

Megan Cooper, MD, PhD
Division of Rheumatology & Immunology

Investigating the origins of immune-mediated disorders in children, the Cooper lab focuses on uncovering genetic mechanisms that contribute to pediatric immune dysregulation. Using advanced genomic sequencing, we identify genetic causes of disease and employ both in vitro and in vivo models to deepen understanding of these conditions. Our work emphasizes leveraging cutting-edge sequencing technologies to reveal mechanisms underlying undiagnosed immune deficiencies in children.

Research profile

Default image

Core Facilities

Empowering research through shared expertise and advanced technology, WashU’s core facilities provide investigators with access to specialized equipment, services and technical support. These centralized resources enable high-quality, cost-effective research across disciplines, fostering collaboration and innovation from basic science to clinical applications.

Default image

Critical Care Medicine

Providing expert care for critically ill children St. Louis Children’s Hospital offers specialized cardiac, pediatric and neurocritical care. Our teams deliver advanced treatment in dedicated intensive care units and provide follow-up programs to support recovery and long-term well-being.

Nurse treats patient

Critical Care Medicine

Providing expert care for critically ill children through innovation and collaboration

Harnessing advanced technology and multidisciplinary expertise, we deliver compassionate, evidence-based care for children in intensive care settings. Our team is committed to improving outcomes through cutting-edge research, rigorous training and a patient-centered approach that supports families during the most challenging moments.

Default image

Critical Care Medicine Fellowship

Division of Pediatric Critical Care Medicine

Preparing graduates for rewarding careers in pediatric critical care medicine, this ACGME-accredited program supports fellows in exploring their individual clinical and academic interests while building a strong foundation of knowledge and experience. The program admits five fellows per year and participates in the NRMP Match for pediatric critical care medicine.

Default image

Di Paola Lab

Jorge Di Paola, MD
Division of Hematology & Oncology

Discovering genetic and biological determinants of bleeding and thrombosis our lab combines expertise in genomics, bioinformatics and molecular biology to uncover mechanisms underlying disorders such as von Willebrand disease and platelet dysfunction. We develop interactive genomic databases, investigate mutations like NBEAL2 and ETV6 and use CRISPR-modified mice to study hemostasis. Our goal is to translate these insights into novel therapies that improve quality of life for patients with bleeding and thrombotic disorders.

Research profile

Default image

Dickson Lab

Patricia Dickson, MD
Division of Genetics and Genomic Medicine

Advancing therapies for MPS disorders, the Dickson Laboratory investigates lysosomal enzyme deficiencies that disrupt glycosaminoglycan metabolism and lead to severe neurological complications. Focused on cerebrospinal fluid delivery of recombinant enzymes, our research demonstrates widespread biodistribution and correction of lysosomal storage in MPS models. By integrating neuroimaging, neuropathology and immune response studies, we bridge bench-to-bedside efforts that include clinical trials aimed at transforming outcomes for patients with these devastating conditions.

Research profile